Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington's disease.
- DOI
- 10.1136/jmg-2026-111509
- Published
- 2026 Jun 25
- Container
- Journal of medical genetics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jmg-2026-111509,
title = {Reverse haplotyping: taking full advantage of 25\% risk testing for the 50\% at-risk parent in Huntington's disease.},
author = {Bijlsma EK and Koopmann TT and de Bot ST and Losekoot M},
year = {2026},
journal = {Journal of medical genetics},
doi = {10.1136/jmg-2026-111509},
url = {https://doi.org/10.1136/jmg-2026-111509}
}RIS
TY - JOUR TI - Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington's disease. AU - Bijlsma EK AU - Koopmann TT AU - de Bot ST AU - Losekoot M PY - 2026 JO - Journal of medical genetics DO - 10.1136/jmg-2026-111509 UR - https://doi.org/10.1136/jmg-2026-111509 ER -
APA
EK, B., TT, K., ST, D. B., & M, L. (2026). Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington's disease.. Journal of medical genetics. https://doi.org/10.1136/jmg-2026-111509
Source records
- pubmed · retrieved 2026-11-10T15:00:37.325Z